Cart
sales@molnova.com
Dihydrosinomenine
CAS No. 65494-41-9
Dihydrosinomenine( ——— )
Catalog No. M38107 CAS No. 65494-41-9
7(R)-7,8-Dihydrosinomenine, a isoquinoline alkaloid that can be isolated from Sinomenium acutum (Menispermaceae), possesses anti-osteoclastogenic effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameDihydrosinomenine
-
NoteResearch use only, not for human use.
-
Brief Description7(R)-7,8-Dihydrosinomenine, a isoquinoline alkaloid that can be isolated from Sinomenium acutum (Menispermaceae), possesses anti-osteoclastogenic effect.
-
Description7(R)-7,8-Dihydrosinomenine, a isoquinoline alkaloid that can be isolated from Sinomenium acutum (Menispermaceae), possesses anti-osteoclastogenic effect.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number65494-41-9
-
Formula Weight331.41
-
Molecular FormulaC19H25NO4
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ji Young Lee, et al. Anti-osteoclastogenic effects of isoquinoline alkaloids from the rhizome extract of Sinomenium acutum. Arch Pharm Res. 2016 May;39(5):713-20.?
molnova catalog
related products
-
UDP-xylose disodium
UDP-xylose disodium is a compound that can be isolated from Cryptococcus laurentii and is a sugar donor that can be used for the synthesis of glycoproteins, polysaccharides, various metabolites and oligosaccharides in plants, vertebrates and fungi.
-
SBE 13 hydrochloride
SBE13 hydrochloride is an effective and specific PLK1 inhibitor (IC50: 0.2 nM); no inhibition om Aurora A kinase, Plk2/3.
-
Memantine
Memantine, an amantadine derivative with some dopaminergic effects, has been proposed as an antiparkinson agent and has may be used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors.
